Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Lakefront Biotherapeutics NV (GXE) vs. Competitors

6 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:GXELakefront Biotherapeutics NVEUR 31.32EUR 2.06B4.2419.72%Moderate SellUnlock the DE:GXE analyst price target with TipRanks PremiumDE:GXEUnlock the DE:GXE top-analyst price target with TipRanks Premium
NL:PHARMPharming GroupEUR 1.12EUR 790.59M34.82-19.41%―Unlock the NL:PHARM analyst price target with TipRanks PremiumDE:GXE vs NL:PHARMUnlock the NL:PHARM top-analyst price target with TipRanks Premium
NL:VVYVivoryon Therapeutics AGEUR 0.66EUR 21.03M-2.88-59.39%―Unlock the NL:VVY analyst price target with TipRanks PremiumDE:GXE vs NL:VVYUnlock the NL:VVY top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:GXELakefront Biotherapeutics NV31.324.8418.28%
NL:PHARMPharming Group1.12-0.27-19.58%
NL:VVYVivoryon Therapeutics AG0.66-0.96-59.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts